These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6977013)

  • 41. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigations into the molecular heterogeneity of pregnancy-specific beta 1-glycoprotein (SP1).
    Hindersson P; Teisner B; Folkersen J; Grudzinskas JG; Westergaard JG
    Placenta; 1981; 2(3):233-40. PubMed ID: 6792620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of pregnancy-specific beta 1-glycoprotein (SP1) and ultrasound in predicting the date of delivery.
    Naiem A; Bersinger NA; Keller PJ; Schneider H
    Br J Obstet Gynaecol; 1988 Feb; 95(2):116-9. PubMed ID: 3280007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antenatal monitoring by pregnancy-specific beta 1 glycoprotein 125I radioimmunoassay].
    Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 1987 Nov; 22(6):329-31, 374. PubMed ID: 3502331
    [No Abstract]   [Full Text] [Related]  

  • 45. [SP-1: parameter for the high risk pregnancy. The pregnancy specific beta 1-glycoprotein in the serum of pregnant women with toxemia].
    Schumann K
    Fortschr Med; 1981 Feb; 99(6):188-91. PubMed ID: 6974125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies in analysis of oncoplacental protein SP1 in vivo and in vitro.
    Engvall E; Miyashita M; Ruosiahti E
    Cancer Res; 1982 May; 42(5):2028-33. PubMed ID: 6175403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease.
    Bremner RD; Nisbet AD; Herriot R; Horne CH; McArdle C; Crawford D; Bohn H
    Oncodev Biol Med; 1981; 2(1-2):55-62. PubMed ID: 6975467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation].
    Briese V; Straube W
    Zentralbl Gynakol; 1984; 106(8):517-23. PubMed ID: 6203263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An immunochemical study of proteins with SP1 determinants in native and acidified pregnancy serum.
    Ahmed AG; Klopper A
    Arch Gynecol; 1981; 230(4):283-91. PubMed ID: 6974542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of gestational age by last menstrual period, by ultrasound scan and by SP1 concentration: comparisons with date of delivery.
    Ahmed AG; Klopper A
    Br J Obstet Gynaecol; 1986 Feb; 93(2):122-7. PubMed ID: 3511954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Placental proteins as tumor markers in human monoclonal gammopathies: results in 109 patients.
    Morrow JS; Levin DL; Kyle RA; Rosen SW
    Tumour Biol; 1985; 6(3):221-32. PubMed ID: 3934736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonimmune complexes of pregnancy-specific beta 1-glycoprotein explain its heterogeneity.
    Tamsen L; Inganäs M; Johansson SG; Karlsson T
    Int Arch Allergy Appl Immunol; 1981; 66(1):21-32. PubMed ID: 6167526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 54. Pregnancy-"specific" beta 1-glycoprotein (SP1): purification, characterization, quantification and clinical application in malignancies (a review).
    Sørensen S
    Tumour Biol; 1984; 5(6):275-302. PubMed ID: 6100221
    [No Abstract]   [Full Text] [Related]  

  • 55. Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy.
    Heikinheimo M
    Oncodev Biol Med; 1980; 1(4-5):287-90. PubMed ID: 6974344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of two pregnancy associated serum proteins with pregnancy specific beta 1-glycoprotein (PS-beta-G)-determinants.
    Westergaard JG; Teisner B; Folkersen J; Hindersson P; Schultz-Larsen P; Svehag SE
    Scand J Clin Lab Invest; 1979 Jun; 39(4):351-9. PubMed ID: 93301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pregnancy-specific beta 1-glycoprotein (SP1) in the serum of women with malignant genital neoplasms].
    Sikorski R; Kapeć E
    Ginekol Pol; 1983 Oct; 54(10):625-8. PubMed ID: 6607863
    [No Abstract]   [Full Text] [Related]  

  • 58. [Studies on pregnancy specific beta 1-glycoprotein (SP1) by enzymeimmunoassay (author's transl)].
    Sawaki Y; Nishiyama Y; Ito M; Hayakawa S; Imaizumi H; Nose Y; Sugiyama Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):53-60. PubMed ID: 7037993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy-specific beta 1 glycoprotein and chorionic gonadotrophin levels following conception.
    Smith DH; Sinosich MJ; Saunders DM
    J Reprod Med; 1981 Nov; 26(11):555-7. PubMed ID: 6978401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pregnancy-specific beta 1-glycoprotein as a prognostic indicator in complications of early pregnancy.
    Ho PC; Jones WR
    Am J Obstet Gynecol; 1980 Oct; 138(3):253-6. PubMed ID: 6968160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.